Viewing Study NCT00003461


Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-03-11 @ 6:54 PM
Study NCT ID: NCT00003461
Status: COMPLETED
Last Update Posted: 2014-08-21
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Sponsor: Duke University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
None Metastatic Cancer View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None localized resectable neuroblastoma View
None recurrent neuroblastoma View
None recurrent adult brain tumor View
None adult craniopharyngioma View
None adult medulloblastoma View
None adult meningioma View
None adult glioblastoma View
None adult oligodendroglioma View
None tumors metastatic to brain View
None adult anaplastic astrocytoma View
None adult mixed glioma View
None adult pineal parenchymal tumor View
None adult central nervous system germ cell tumor View
None adult grade III meningioma View
None adult pilocytic astrocytoma View
None adult giant cell glioblastoma View
None adult gliosarcoma View
None adult pineal gland astrocytoma View